2006
Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, and Moore RD. “Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy”, Am J Epidemiol 2006;163:412-420.
Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990 – 2003. AIDS 2006 Feb 14;20(3):437-44.
Sheth AN, Moore RD, and Gebo KA*. “Provision of General and HIV-Specific Health Maintenance in an Urban HIV Clinic”, AIDS Care and STDs 2006 May;20(5):318-25.
2005
Gebo KA, Fleishman JA, Conviser R, et al. “Racial and Gender Disparities in Receipt of HAART Persist in a Multi-State Sample of HIV Patients in 2001”, J Acquir Immune Defic Syndr 2005;38:96-103
Moore RD, Keruly JC, Gebo KA, Lucas GM. “An improvement in virologic response to HAART in clinical practice from 1996-2002”, J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):195-8.
Gebo KA, Fleishman JA, Reilly ED, Moore RD, for the HIV Research Network. High Rates of Primary Mycobacterium Avium Complex and Pneumocystis Jiroveci prophylaxis in the United States. Medical Care 2005;43(9 Suppl):III23-30.
Rutstein R, Gebo KA, Siberry GK, Flynn PM, Spector SA, Sharp VL et al. “Hospital and Outpatient Health Services Utilization Among HIV-Infected Children in Care 2000-2001”, Medical Care 2005 43(9 Suppl):III31-39.
Rutstein R, Gebo KA, Flynn PM, Fleishman JA, Sharp VL, Siberry GK et al. “Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV-Infection on HAART”, Medical Care 2005 43(9 Suppl):III15-22.
Betz ME, Gebo KA, Barber E, Sklar P, Fleishman JA, Reilly ED, Mathews WC. “Patterns of Diagnosis in Hospital Admissions in a Multi-State Cohort of HIV+ Adults in 2001”, Medical Care 2005;43(9 Suppl):III3-14.
Fleishman JA, Gebo KA, Reilly ED, Conviser R, Mathews WC, et al, for the HIV Research Network. “Hospital and Outpatient Health Services Utilization Among HIV-Infected Patients in Care 2000-2001”, Medical Care 2005,43(9 Suppl):III40-52.
Gebo KA, Kalyani R, Moore RD, and Polydefkis M, “The Incidence of, Risk Factors for, and Sequelae of Herpes Zoster Among HIV Patients in the HAART Era”, JAIDS 2005;40:169-74.
Gebo KA. HIV infection in older patients: new therapies. Hospital Pharmacy Europe 2005; September/October 22:19-21.
Gebo KA, Fleishman JA and Moore RD. “Hospitalizations for Metabolic Conditions, Opportunistic Infections, and Injection Drug Use among HIV Patients: Trends between 1996-2000 in 12 States”, JAIDS, 2005 Oct; 40(5):609-16.
Gebo KA and Moore RD. “Managing HIV in middle age and older populations”, Aging Health 2005;1(3),395-407.
2004
Gebo KA, Gallant JE, Keruly JC, and Moore RD. “Absolute CD4 versus CD4 Percentage for Predicting the Risk of Opportunistic Illness in HIV-Infection”, J Acquir Immune Defic Syndr. 2004 15;36(5):1028-1033
Mahadevia PJ, Gebo KA, Pettit K, Dunn JP, and Covington M. “The Epidemiology, Treatment Patterns and Costs of CMV Retinitis in the Post HAART Era among a National Managed Care Population”, J Acquir Immune Defic Syndr 2004 Aug 1;36(4):972-977
Gebo KA and Moore RD. “Treatment of HIV-infection in the Older Patient”, Expert Review of Anti-infective Therapy 2004 Oct;2(5):733-43
Himelhoch S, Moore RD, Treisman G, and Gebo KA*. "Does Presence of Mental Disorder in AIDS Patients Affect the Initiation of Antiretroviral Treatment and Duration of Therapy?"
J Acquir Immune Defic Syndr 2004 37(4):1457-1463
Harrington SM, Ross TL, Gebo KA and Merz WG. “Vancomycin Resistance, esp and Strain Relatedness: A 1-Year Study of Enterococcal Bacteremia”, J Clin Micro 2004 42:5895-5898
